Akoustis Technologies, Inc. (AKTS) AI Stock Analysis

Akoustis Technologies, Inc., operating via its subsidiary Akoustis, Inc., provides advanced radio frequency (RF) filter products to the mobile wireless device industry globally across the United States, Asia, Europe, and other regions. The company operates in two segments: Foundry Fabrication Services and RF Filters. The Foundry Fabrication Services segment offers engineering review and microelectromechanical systems foundry services. The RF Filters segment delivers amplifier and filter products designed for smartphones, tablets, cellular infrastructure, Wi-Fi customer premise equipment, and defense sectors. Akoustis is headquartered in Huntersville, North Carolina.

Akoustis grew its revenue from $1.8M in FY2020 to $15.3M in FY2021 and $27.1M in FY2023. Revenue fell 94.5% in FY2024 to $1.5M before rebounding 336.9% to $6.5M in FY2025. Gross margin was 100.0% in both FY2024 and FY2025, while operating margin stood at -1149.5% in FY2025. Annual net loss widened from $44.0M in FY2024 to $63.7M in FY2025, with FY2025 EPS at -$16.52. For the latest quarter ended June 30, 2026, quarterly revenue grew 111.4% year-over-year, bringing trailing twelve-month revenue to $10.1M.

As of June 30, 2026, Akoustis held $517.3M in cash and short-term investments against total debt of $11.2M, resulting in net cash of $506.1M. Total assets stood at $557.6M, shareholders' equity was $484.8M, and the current ratio was 16.33. Operating cash flow in FY2025 was -$64.1M, and free cash flow was -$73.7M. In FY2025, capital expenditures were $9.6M, while R&D expenses totaled $67.5M. The 5-year share count change was 4.5%.

At a share price of $15.06 on October 16, 2026, Akoustis had a market cap of $837.6M and an enterprise value of $589.9M. The stock traded at a price-to-sales multiple of 83.3x and an EV-to-revenue multiple of 58.6x, compared to a price-to-sales multiple of 4.1x for the median of its US-listed Healthcare peers. Its price-to-book ratio stood at 2.3x. The 52-week trading range spans from $14.72 to $34.19, while the S&P 500 benchmark gained 16.8% over the past year and 83.0% over five years.

Akoustis has 9 Strong Buy ratings and 1 Buy rating from analysts. The mean price target is $35.39, which is 135.0% above the last close of $15.06. For the fiscal year ending December 31, 2026, consensus estimates project revenue of $10.6M and an EPS of -$1.68. For the next fiscal year, 8 analysts project revenue of $10.3M and an EPS of -$2.14. Over the last four quarters, the company beat EPS estimates 1 time. The next earnings date is November 12, 2026.

This page is an AI-written research summary of Akoustis Technologies, Inc. (AKTS). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: AKTS income statement, AKTS balance sheet, AKTS key metrics, AKTS analyst forecast, AKTS chart. See the AKTS stock overview for the latest quote and news.